Two Sigma Securities, LLC Spectrum Pharmaceuticals Inc Transaction History

Two Sigma Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.38 - $1.07 $29,581 - $83,295	-77,846 Reduced 76.02%	24,553 $18,000
Q4 2022 Feb 14, 2023	BUY	$0.32 - $0.52 $18,780 - $30,518	58,689 Added 134.27%	102,399 $37,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $18,795 - $68,187	43,710 New	43,710 $19,000
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.4 $8,558 - $17,116	-12,226 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.63 - $1.59 $7,702 - $19,439	12,226 New	12,226 $16,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $26,179 - $49,885	-20,614 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.82 $44,320 - $78,745	20,614 New	20,614 $45,000
Q2 2020 Aug 14, 2020	SELL	$2.11 - $3.38 $28,759 - $46,069	-13,630 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $24,942 - $47,023	13,630 New	13,630 $32,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.